Results 111 to 120 of about 2,650 (185)

Emerging drugs for the treatment of diabetic retinopathy [PDF]

, 2020
Caccioppo, Andrea, Castellino, Niccolò, Porta, Massimo, Reibaldi, Michele, Striglia, Elio   +4 more
core   +1 more source

Efficacy of brolucizumab and ranibizumab in diabetic macular edema and neovascular age-related macular degeneration: insights from a case series. [PDF]

Ann Med Surg (Lond)
Hossain B, Rahmatullah S, Ahmed T.
europepmc   +1 more source

Proactive Post-Injection Monitoring in Brolucizumab Therapy: A Study on Intraocular Inflammation and Treatment Outcomes

Clinical Ophthalmology
Manoj Soman,1,2 Apoorva Jadhav,1,2 Abhaya Balakrishnan,1,2 Jay U Sheth,3 Unnikrishnan Nair1,2 1Department of Vitreoretinal Services, Chaithanya Eye Hospital and Research Institute, Trivandrum, India; 2Department of Research, Chaithanya Innovation in ...
Soman M, Jadhav A, Balakrishnan A, Sheth JU, Nair U   +4 more
doaj  

Intravitreal Brolucizumab Use for Retinal Vascular Diseases in Resource-Constrained Settings: A Retrospective Study From Bangladesh. [PDF]

Cureus
Moniruzzaman M, Azzam M, Nessa MS, Ahmed A, Ahmed T, Rahman M.   +5 more
europepmc   +1 more source

Real-world efficacy and safety of Brolucizumab injection in vitrectomised eyes (BIVE) - a prospective multicentric study. [PDF]

BMC Ophthalmol
Boral SK, Agarwal D, Chakraborty D, Das A, Sinha TK.   +4 more
europepmc   +1 more source

Measurement of Acute Intraocular Pressure Elevation Immediately After Intravitreal Anti-VEGF Injection and Analysis of Prefilled Syringe Accuracy. [PDF]

Clin Ophthalmol
Itoh K, Negishi M.
europepmc   +1 more source

International Classification System for Ocular Complications of Anti-VEGF Agents in Clinical Trials [PDF]

\ua9 2024 American Academy of OphthalmologyPurpose: Complications associated with intravitreal anti-VEGF therapies are reported inconsistently in the literature, thus limiting an accurate evaluation and comparison of safety between studies.
Bakri SJ, Balas M, Berrocal A, Chang A, Garg S, Gemmy Cheung CM, Hillier RJ, Holz FG, Huang R, Johnson MW, Kaiser PK, Kertes PJ, Lai TYY, Muni RH, Noble J, Park SS, Paulus YM, Popovic MM, Querques G, Rachitskaya A, Ruamviboonsuk P, Sadda SR, Saidkasimova S, Sandinha MT, Sarraf D, Steel DH, Terasaki H, Weng CY, Williams BK, Wu L   +29 more
core  

Quantitative Optical Coherence Tomography Angiography Biomarkers Following a Switch to Brolucizumab in Neovascular Age-Related Macular Degeneration. [PDF]

Korean J Ophthalmol
Lee S, Choi J, Yu SY, Kim K.
europepmc   +1 more source

Short-Term Outcomes of Intravitreal Brolucizumab Injection and Sub-Tenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema: A Pilot Study. [PDF]

J Vitreoretin Dis
Nagayama M, Terasaki H, Mihara N, Funatsu R, Okamura K, Miyake S, Sonoda S, Sakamoto T.   +7 more
europepmc   +1 more source

Comparative evaluation of stability, efficacy, and sterility in five repackaged intravitreal anti-vascular endothelial growth factor medications. [PDF]

Sci Rep
Thunwiriya P, Phetruen T, Chaiwijit P, Tonawannakorn C, Dekham K, Thadtapong N, Chaturongakul S, Charoensawan V, Chanarat S, Pakotiprapha D, Hanutsaha P.   +10 more
europepmc   +1 more source